Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Island Labs has received Natural Health Product (NHP) approval from Health Canada for Stemcelex. Stemcelex is a patented (PCT filed) product that has demonstrated hair growth for men and women on all areas of the scalp, including areas affected by androgenic alopecia (pattern baldness).
Subscribe to our email newsletter
The company claims that Stemcelex naturally stimulates the population of stem cells within the hair follicle. Over 30 years in development, the product is safe and has shown to produce no adverse side effects.
Island Labs has appointed Lorne Meikle as the company’s new chairman. He will direct the global licensing and commercialisation of Stemcelex.
Having served as CEO for nine biotechnology companies, Mr. Meikle is currently president and CEO of Management Dynamics, LOB Ordeins and CEO of Neuroimage. He is also chairman and director of Quest PharmaTech.
Mr. Meikle said: “Stemcelex research indicates that this innovative new product offers significant hair growth improvement over currently marketed products.”